Searchable abstracts of presentations at key conferences in endocrinology

ea0031p7 | Bone | SFEBES2013

Alterations of CLC-5 expression, function and trafficking in Dent's disease

Gorvin Caroline , Wilmer Martijn , Piret Sian , Harding Brian , van den Heuvel Lambertus , Jat Parmjit , Lippiat Jonathan , Levtchenko Elena , Thakker Rajesh

Dent’s disease, due to mutations in the chloride/proton antiporter, CLC-5, represents one form of familial hypophosphataemic rickets. Dent’s disease patients also have: low-molecular-weight-proteinuria; hypercalciuria with nephrolithiasis and renal failure; and urinary loss of parathyroid hormone and vitamin D-binding protein, due to defective receptor-mediated endocytosis within the renal proximal tubule. However, there is variability in these clinical phenotypes su...

ea0028p186 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Mutations of the Chloride/Proton Antiporter, CLC-5, lead to Impaired Endosomal Acidification in Human Proximal Tubule Epithelial Cell-lines

Gorvin Caroline , Wilmer Martijn , Piret Sian , Harding Brian , Lippiat Jonathan , O'Hare Michael , Jat Parmjit , Wrong Oliver , van den Heuvel Lambertus , Levtchenko Elena , Thakker Rajesh

Dent’s disease is a renal proximal tubular disorder characterised by low-molecular-weight proteinuria, glycosuria, hypercalciuria, phosphaturia, nephrolithiasis and abnormal urinary loss of other proteins which include insulin, parathyroid hormone (PTH) and vitamin D-binding protein, due to defective receptor-mediated endocytosis (RME). Mutations in CLC-5 cause Dent’s disease-1 whilst mutations in OCRL1 cause Dent’s disease-2 and the oculocerebrorenal syndrome o...